BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Covic A, Jackson J, Hadfield A, Pike J, Siriopol D. Real-World Impact of Cardiovascular Disease and Anemia on Quality of Life and Productivity in Patients with Non-Dialysis-Dependent Chronic Kidney Disease. Adv Ther 2017;34:1662-72. [PMID: 28578500 DOI: 10.1007/s12325-017-0566-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 van Haalen H, Jackson J, Spinowitz B, Milligan G, Moon R. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data. BMC Nephrol 2020;21:88. [PMID: 32143582 DOI: 10.1186/s12882-020-01746-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
2 Shibata T, Nomura Y, Takada A, Ueno M, Katashima M, Yazawa R, Furihata K. Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects. Clin Pharmacol Drug Dev 2019;8:304-13. [PMID: 29966038 DOI: 10.1002/cpdd.597] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
3 Hiramatsu T, Okumura S, Asano Y, Mabuchi M, Iguchi D, Furuta S. Quality of Life and Emotional Distress in Peritoneal Dialysis and Hemodialysis Patients. Ther Apher Dial 2020;24:366-72. [DOI: 10.1111/1744-9987.13450] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
4 Chertow GM, Pergola PE, Agarwal R, Block GA, Farag YMK, Jardine AG, Koury MJ, Luo W, Khawaja Z, Lewis EF, Matsushita K, McCullough PA, Parfrey PS, Wittes J, Walters KA, Tseng C, Lin T, Sarnak MJ, Vargo DL, Winkelmayer WC, Eckardt KU. Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics. Am Heart J 2021;235:1-11. [PMID: 33129989 DOI: 10.1016/j.ahj.2020.10.068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shibata T, Nomura Y, Takada A, Aoki S, Katashima M, Murakami H. Evaluation of the effect of lanthanum carbonate hydrate on the pharmacokinetics of roxadustat in non‐elderly healthy adult male subjects. J Clin Pharm Ther 2018;43:633-9. [DOI: 10.1111/jcpt.12729] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
6 Yu PH, Lin MY, Chiu YW, Lee JJ, Hwang SJ, Hung CC, Chen HC. Low serum iron is associated with anemia in CKD stage 1-4 patients with normal transferrin saturations. Sci Rep 2021;11:8343. [PMID: 33863963 DOI: 10.1038/s41598-021-87401-w] [Reference Citation Analysis]
7 Wish JB. Treatment of Anemia in Kidney Disease: Beyond Erythropoietin. Kidney Int Rep 2021;6:2540-53. [PMID: 34622095 DOI: 10.1016/j.ekir.2021.05.028] [Reference Citation Analysis]
8 Nangaku M, Farag YMK, deGoma E, Luo W, Vargo D, Khawaja Z. Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients. Nephrology Dialysis Transplantation 2021;36:1244-52. [DOI: 10.1093/ndt/gfaa060] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
9 Pramod S, Goldfarb DS. Challenging patient phenotypes in the management of anaemia of chronic kidney disease. Int J Clin Pract 2021;:e14681. [PMID: 34331826 DOI: 10.1111/ijcp.14681] [Reference Citation Analysis]
10 Carlson J, Gerson AC, Matheson MB, Manne S, Warady BA, Hooper SR, Lande M, Harshman LA, Johnson RJ, Shinnar S, Kogon AJ, Furth S. A longitudinal analysis of the effect of anemia on health-related quality of life in children with mild-to-moderate chronic kidney disease. Pediatr Nephrol 2020;35:1659-67. [PMID: 32333284 DOI: 10.1007/s00467-020-04569-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Akizawa T, Okumura H, Alexandre AF, Fukushima A, Kiyabu G, Dorey J. Burden of Anemia in Chronic Kidney Disease Patients in Japan: A Literature Review. Ther Apher Dial 2018;22:444-56. [PMID: 30022586 DOI: 10.1111/1744-9987.12712] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
12 George S, McCann M. A nurse prescriber-led protocol for anaemia management in established haemodialysis patients: A retrospective study. J Clin Nurs 2020;29:2535-43. [PMID: 32267027 DOI: 10.1111/jocn.15275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Song HY, Wei CM, Zhou WX, Hu HF, Wan QJ. Association between admission hemoglobin level and prognosis in patients with type 2 diabetes mellitus. World J Diabetes 2021; 12(11): 1917-1927 [PMID: 34888016 DOI: 10.4239/wjd.v12.i11.1917] [Reference Citation Analysis]
14 Schmidt C, Allen S, Kopyt N, Pergola P. Iron Replacement Therapy with Oral Ferric Maltol: Review of the Evidence and Expert Opinion. J Clin Med 2021;10:4448. [PMID: 34640466 DOI: 10.3390/jcm10194448] [Reference Citation Analysis]
15 Groenendaal-van de Meent D, den Adel M, van Dijk J, Barroso-Fernandez B, El Galta R, Golor G, Schaddelee M. Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects. Eur J Drug Metab Pharmacokinet 2018;43:685-92. [PMID: 29752643 DOI: 10.1007/s13318-018-0480-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
16 Nangaku M, Kondo K, Ueta K, Kokado Y, Kaneko G, Matsuda H, Kawaguchi Y, Komatsu Y. Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study. Nephrol Dial Transplant 2021;36:1731-41. [PMID: 33650630 DOI: 10.1093/ndt/gfab055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
17 Hanna RM, Streja E, Kalantar-Zadeh K. Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin. Adv Ther 2021;38:52-75. [PMID: 33123967 DOI: 10.1007/s12325-020-01524-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]